Tobias Silberzhan, Partner at McKinsey Berlin Office

Leadership Insights for Healthcare Innovation with Tobias Silberzhan, Partner at McKinsey Berlin Office transcript powered by Sonix—easily convert your audio to text with Sonix.

Leadership Insights for Healthcare Innovation with Tobias Silberzhan, Partner at McKinsey Berlin Office was automatically transcribed by Sonix with the latest audio-to-text algorithms. This transcript may contain errors. Sonix is the best audio automated transcription service in 2021. Our automated transcription algorithms works with many of the popular audio file formats.

Saul Marquez:
Hey everyone, Saul Marquez here. Have you launched your podcast already and discovered what a pain it could be to keep up with editing, production, show notes, transcripts, and operations? What if you could turn over the keys to your podcast busywork while you do the fun stuff like expanding your network and taking the industry stage? Let us edit your first episode for free so you can experience the freedom. Visit smoothpodcasting.com to learn more. That’s smoothpodcasting.com to learn more.

Saul Marquez:
Welcome back to the Outcomes Rocket, Saul Marquez here today, I have the extraordinary privilege of hosting Dr. Tobias Silberzhan. He’s a trained biochemist and immunologist. He’s a partner at McKinsey’s Berlin office. And the focus of his work is health care innovation. Tobias leads the Global Health Tech Network, a community of 500 plus digital health startups. And he hosts the Med Tech R&D Industry Roundtable and two pharma R&D industry roundtables with McKinsey Germany. Tobias leads the My Experience Initiative that helps colleagues improve their health and well-being by better nutrition, sleep, fitness, and stress management. Tobias is married and lives in Berlin with his wife and two children, which is where we’re connecting him today. Tobias, such a pleasure to have you here on the podcast today.

Tobias Silberzhan:
Thanks for having me.

Saul Marquez:
Absolutely. So we’re going to dive into a lot of the work that you’re up to in McKinsey, but also outside of it. I mean, you just have such a great presence in the health care sphere globally, but also in Europe. And so I’d love to, first of all, get to know you a little bit better. And for the listeners and viewers to get to know you better, what inspires your work in health care?

Tobias Silberzhan:
Well, so, you know, on the one hand, being a biochemist immunologist, there is some professional background and connection there that got me got me into the health care industry. On the other hand, my inspiration and my motivation come largely from my personal story. I lost several family members to cancer when my father died of cancer four years ago. And then also my two children were born. It felt like the half time in my life. I had the father for the first half of my life and then the second half of my life. I’m a father myself and that half time period. I felt very much like, what do I want to do in the second half of my life? And what work do I find meaningful? And to cut the long story short, I decided that I would dedicate my work entirely on health care innovation and to health care innovation and the question of how improvements can be achieved and innovations being promoted in the health sector.

Saul Marquez:
Wow. Well, sorry to hear about your dad Tobias you know. It’s never easy. And then your kids came, which is a blessing. And then this just becomes like the center point and your new trajectory. And so you’re on this journey to improve health care, health care innovation. Tell us a little bit about what you’re doing and feel free to focus on the many organizations that you’re a part of outside of McKinsey or inside of McKinsey, like take this where you want to take it. And how are you adding value to the health care ecosystem?

Tobias Silberzhan:
Yeah, I’m happy to talk about this Saul. Well, since I work on innovation topics with medical device companies, pharma companies, digital health startups, and health ministries across Europe, I see that that often there is a lot of opportunity around scaling of health care innovation. And the second area that I think is a very important area is what the health system of the future looks like, right? As a combination of digital and non-digital offers an example in western European countries, the health system already has more than one hundred interventions available to deal with such a widespread disease like diabetes. And if we simply pack on a novel twenty-five or fifty digital solutions we’ll probably not improve the well-being of patients or not be very helpful to citizens. And instead, I think we should think about how we want to help citizens to live healthily in the future and how should we think about the target image of our health system, more like managing health and rather than waiting for people to become sick and then trying to help fix the problem. And as a company, we are trying to add value in these areas by working very much on health care as a multidimensional opportunity. And I just want to mention four things here. First, we very much look at the value perspective of health care and also health care innovation, which these days is a lot around digital health. So, for example, when we look at the twenty-five main digital health categories, we look at things like what value would the digital health solutions add to a health system if they were fully implemented. And looking at both from a patient outcomes perspective as well as from the health system perspective and health care economic perspective.

Tobias Silberzhan:
Secondly, bringing in health analytics and these days, almost more importantly, the industrialization of health analytics. So in that sense, our health care analytics unit comes from Formula One car racing. They bring a huge focus on performance and speed in Formula One. You need data engineering to get back to you and deliver something within days or weeks, not in years. So also, in that sense, it’s not enough also to develop certain use cases. It’s more about productionizing these cases, managing these algorithms in a smart way. Then third – design – is in my opinion, a huge thing for health care. Few people know about that, right. But in the last few years, my company has become one of the top 10 design firms globally, both in terms of industrial design for physical products, but also the design of drugs and digital services. So my design colleagues in Sweden just helped design a surgical robot, for example, for which they’ve just won the Red Dot design award. And the important thing is that really to bring it all together. If you bring a value-focus and an analytics-capability and a design capability altogether, think about it. How would it work in the health system and what capability-building do you need to do and how to do some of the incentives so the economics be changed to make it really work. But that is sort of what I’m excited about and what we are trying to work on.

Tobias Silberzhan:
Yeah, that’s really interesting. And to be as you mentioned, there are a hundred ways to manage diabetes. Throw another twenty-five. How is that even going to guarantee that you’re hitting the mark with the value you’re trying to deliver? How is it going to guarantee better health for people, better return on investment for employers? These are all questions we need to be thinking about. Very cool thought process here. The three pillars, value, analytics, and design. I think it’s certainly something that we could probably learn more about from you. So talk to us about how the approaches you guys are taking make it different than what’s available today. And some examples there would be nice.

Tobias Silberzhan:
Thank you. I’m happy to talk about that, Saul. So I think I first want to start with the purpose. Sort of the purpose that I had. I spoke about it in the first question. But also the purpose of our company is to help create positive and enduring change in the world. And that is pretty much the underlying thinking that we want to contribute and from where we are coming. When we work on digital health, as an example, we then look at this underlying value that we just talked about. And to do that, for example, we built a model that that looks at more than five hundred publications in the digital health space academic publications. We looked at what’s the published evidence and the impact of these solutions with that map, with the health care spend categories in various countries to then be able to say, what is the underlying value that, for example, the patient remote monitoring brings to our health system on a patient perspective level, but also on a health system, financial perspective? For a country like Germany, where I’m from, that would be a three-point three billion euros and telemedicine would be another category. That’s a bit where we are sort of trying to ground everything into the value that this delivers in the health system. And then I think the second thing that that I often feel is different is thinking about it sort of beyond the current silos. So a lot of people this year talk about health care ecosystems. So happy to use that term. But at the end of the day, for me, the question is how can we achieve behavioral change both on the patient and citizen perspective, but also behavior change on a system-level provider, so be it health insurances. In that respect, I find it helpful to think about these ecosystems and journeys. And when I look globally, Saul, I currently see in a slightly simplified view six main archetypes of health ecosystems being built. There is sort of the pharmacy primary care ecosystem where like a company is for example, in Europe are combining pharmacy with primary care services. That’s something that has been two separate silos, at least in Europe since the medieval ages. And then there are sort of other archetypes being built combining primary care with secondary care solutions, other archetypes that are combining health insurance with primary care services. Like for example what Qing Ahn is doing in China. Actually, that’s an interesting approach from my perspective, when I think about this health care ecosystem, archetypes, are they better or could they be better in creating that behavior change? I’ve done a number that I always find fascinating is that the German physicians spend on average eight minutes with their patients, right, and then thinking through could we design a journey or an ecosystem that actually helps the citizens and the patients to change that behavior towards more healthy choices and didn’t. In many case examples, I would say I’m a pretty motivated patient, but I can’t change my behavior sustainably after an eight-minute intervention or a session with the doctor. So in that sense, thinking about it more from a journey perspective or putting it the other way round, what are the touchpoints that a citizen like Saul has over the years from a health perspective? And how could we support him to make healthy choices along these touchpoints? I think that is different and I find it helpful to achieve that that change.

Saul Marquez:
Yeah, thanks for that Tobias, and you mentioned a couple of models, all of them involving primary care, this focus on primary care compared to specialist care. I think this is something that we’re all becoming more cognizant of, the importance of it. And you also mentioned the importance of not just having those touchpoints, those eight minutes, having that continuity, the continuity of care, and that’s where the difference is made. So I appreciate that. How has what you guys are doing improved outcomes or made business better? So these are some of the insights. How do they translate into the day-to-day?

Tobias Silberzhan:
Well, you know, most projects, as you know, are confidential. But I’m happy to say that, you know, for example, in 2020 that spin-off cost quite a lot of work in health care with the COVID-19 pandemic. And I think that digital health is a beautiful example of how digital health is actually saved people’s lives. And I’ve seen that firsthand, how digital health and how precision medicine can save lives. So that’s why I’m motivated to bring more of these benefits to health systems. If we use COVID-19 as an example, I’ll just talk about a pilot project that I find pretty cool in the UK there are people using patient remote monitoring for the management of COVID-19 patients. They called it virtual worlds. And if people are interested, they can look at a brief article about it in the British Medical Journal. And what pretty much the objective of that project was twofold. First of all, trying to spot complications really, really early, and be able to medically intervene and help these patients. So and then the second objective was to have a tool or a digital health solution, rather, that enables the doctor to continuously monitor that patient instead of having to make a yes-no decision. The moment that this COVID-19 patient presents. And as we learn from some of the cases in March, April, a lot of patients in such a situation were actually hospitalized because the doctor felt, oh, this is sort of my third or fourth covid-19 patient that I see.

I’m not quite sure how this will involve the patient. Doesn’t look good. So let’s hospitalize that patient to be on the safe side. And if you apply patient remote monitoring to COVID 19 patients. You actually have a few very interesting effects. On the one hand, when patients submit, let’s say, that body temperature, that oxygen saturation, and the blood and let’s say a survey around breathlessness and breathing problems. if they submit that three times a day, then you are able to spot complications really early. And I’m just quoting the number from that publication. Two hundred and forty-four patients were in the very first initial pilot cohort and zero of them died. And I think that is a remarkable result, especially since most people seem to be talking about telemedicine and other COVID-19 related tools. But I’m personally very excited about this, this result, how patient remote monitoring can actually help. And then the other feedback that I hear is on the doctor’s side, doctors like the feeling of safety and security that such a digital health solution can give to them because they know the patient might not be looking great. But I don’t have to hospitalize the patient, by the way, because in three, four, or five hours, I get the next three and. And when things really deteriorate, I can step in very, very early. There are even examples where patients with covid-19 had complications onset plus including pulmonary embolism, and even those patients could be safe because the doctors saw it really early and could intervene.

Tobias Silberzhan:
And also the patient feedback is extraordinarily positive. People saying that they felt looked after. And finally, finally, if you’re if you just apply that to a health system, and sort of this autumn, winter, at least in the northern hemisphere, this autumn-winter situation that we have now, think about that. You are the doctor looking after COVID-19 patients, Right., and you’ve got sort of then a dashboard in front of you where you would then can easily in a prioritized way, look after one hundred two hundred patients. And the feedback from doctors is that in this prioritized list of patients where the patients with the highest fever are the lowest oxygen saturation at the top, you can take about 10 minutes and then you scroll through your list. That is sort of the live feedback that I found from doctors. Anyway. So that’s a bit, as you can see the outcomes that I’m very excited about. And of course, that doesn’t that is not just limited to COVID-19. All sorts of diseases could benefit from remote monitoring, both in the COVID-19 space, where you then can envisage remote monitoring as a safe pathway for people with COPD, fibrosis, or oncology to have that lifeline to that doctor that sometimes got interrupted in spring. But some of the doctors in this program actually said, wow, this is so cool. Can I actually use it also for just non-COVID-19 patients?

Saul Marquez:
Yeah, you know, and that is exciting to see the application of remote patient care to other things outside of COVID, because a lot of times these chronic diseases that need continuous management just get those episodic visits. And then you mentioned clinicians’ safety. And I think the concern of clinicians’ safety has been elevated due to the pandemic, the use of digital technologies to manage, prioritize and sometimes even control a monitor remotely could be very useful. So, you know, this is certainly an exciting time. Having the right model to approach this environment is critical. You’ve given us some high-level examples. Obviously, with the short time that we have today, we can’t go deep. But you’ve given us some good glimpses into some models that could work as companies and organizations and providers address some of the challenges and opportunities today Tobias what would you say is one of the biggest setbacks that could be experienced, maybe something that you guys went through and what was a key learning that that came out of that or that could come out of that?

Tobias Silberzhan:
I think there are quite, quite a few learnings, I would say, with digital health setbacks and learnings, both on a subsystem level as well as a personal level. And if I start with the system level, a lot of the setbacks can be explained by who owns and who owns the money today this digital health solution or this innovation is addressing. It sounds like almost a shark tank on Dragons Den kind of question, but unfortunately, itis very true because the health economics, how they are set today as a sort of incentivizing certain behaviors, they are incentivizing at the citizen level, on the physician level, on the health insurance level. In that sense, when I work in digital health solutions, we usually look at that directly. On the one hand, look at the underlying value of the health system, as we talked about before. On the other hand, we look at sort of the economic incentives and the economic flows, who’s earning what for which type of activity in that sense. I think also how people in Europe and sort of on the European continent are currently thinking about it. Right., which has been part of the health care innovation roadmap for Europe for years, from 2020 to 2030. Some of the setbacks from the past where it’s been very hard to implement things due to incentives, the question has now become how can health economics and health care incentives also be adjusted in a way that we actually promote health instead of trying to fix disease?

Tobias Silberzhan:
In that sense, that just been some of the setbacks that I’ve seen in the past, but also where I’m hopeful that some of the discussions that are happening today about future health care economics, future health care incentives are actually promising and much needed. And if I think about it on a more personal level, Right. one of my own setbacks that I’ve had is and was my own realization a few years ago how I personally dealt with health. and how I dealt with my health and how I dealt with stress. I realized that it wasn’t very sophisticated. And I have to admit that, you know, I started caring about stress management and how it relates to health and your own personal situation. About five years ago, when I realized that I had I felt like I had a wonderful life, a wonderful wife, a wonderful family, a wonderful job. I worked on things that I really cared about, but I personally felt quite stressed on a Day-To-Day level. And for years I had struggled with what we could describe as recharging my batteries. I was brought up with the principle that you first finish your work and then you relax. But what if, at least in my perception at the time, work never ends. There are always more cool things that you can do, right. But as part of your work, it sort of cool digital health, health care, innovation projects outside of work, etc. So in the past, that meant that I work very long hours. I slept too little and felt that the next day and so on. As you know, I’m a biochemist. So so then I also looked into this topic from a scientific perspective, and then you’ll find that it’s pretty obvious Right. lack of sleep, for example, directly correlates with stress and feelings of anxiety Right. So it’s a real vicious cycle.

Saul Marquez:
It is, yeah. You know, I appreciate you sharing that. I mean, I feel like as busy professionals, we all go through it and, you know, and it’s normal and we have to stop and we have to evaluate our own personal routines. You know, I was working with the trainer for a long time, and then I stopped, and then I just noticed myself gaining weight. And before you know it, like three, four months, I’m like, OK, get back with the program, you know? And so it certainly is challenging. And now the COVID layer in the COVID challenge. On top of that, it does become more challenging. So I appreciate your openness to sharing some of those things Tobias. And I think you provide a good example of what it is to be able to manage a lot, but yet still get some good sleep, enjoy your family while you’re at it. So Tobias, I really appreciate you sharing the challenge and having to take care of yourself better. How did you do it? Like what did you do to solve it?

Tobias Silberzhan:
Good question. For me, it’s been a journey and to be honest, I’m still on the journey and I at least try to improve as I go along. If I think back five years, the first thing was that I started working with a coach. I personally sort of saw it as initially I saw it as a stress management topic. So then I started experimenting with meditation and that was actually a huge game-changer for me. Right. initially, I was quite skeptical. I was very much the person I lived in my head. Right. For me, it was sort of always what’s the story in my head kind of situation? And then I realized through meditation that there is actually so much more. And for people who are really good at that, they probably start laughing now. But, you know, for me, it was the realization of, OK, that is sort of the story in my head. And then there is sort of the emotions underneath and then underneath the emotions, there is sort of the body sensations. And so in my example, that would be the story in my head would go sort of go on and go on. And then I would become aware that actually there is now stress and anxiety is an underlying emotion here. The body sensation connected to that, at least for me, was and still is a very tight knot in my stomach. When I realized that, that was already a big step forward for me. When I then also realized that when I meditate and I stop thinking about positive things like, for example, having my son or my daughter lap sitting with me on my lap or so, I could really feel how that tightness in my stomach started releasing. That was sort of bit the start of the journey. I then also got into improving my sleep and particularly my deep sleep. That’s also what digital health comes in again with wearables. And, you know, to cut a long story short, today, I sleep a lot more with a healthy amount of deep sleep. And it’s incredible how this change has paid dividends. I’m a happier person. I feel like I’m also a better husband and father and also feels like I’m more successful at work.

Tobias Silberzhan:
And this has actually led to me also being asked to lead the program that we at McKinsey called my experience. And that’s a program where I’m happy and very excited to do health care innovation within our company. It’s a program that pretty much helps people be at their best, and that means that includes a lot of the things related to health and well-being that we talked about, include thinking about your purpose. It includes sleep, fitness, nutrition, stress management, and anxiety management, And I’m very happy to lead this program for McKinsey Germany and see the positive impact this program has on individual companies and also the company as a whole.

Saul Marquez:
Oh, that’s awesome. Tobias, it’s great that you didn’t just stop at yourself Right. You went beyond and said, wow, like meditation, better sleep distresses me. I want to share this with my team. And so kudos to you for doing that. That’s a great story. So let’s take a step back here and look at the economy, the world, the business. What are you most excited about today?

Tobias Silberzhan:
This year? Of course, I’m excited that hopefully there is progress being made on COVID-19 and the pandemic. But beyond that, I’m very excited about some of the work that colleagues have done. It’s a study called Prioritizing Health. It was done by a think tank, the McKinsey Global Institute. And then my colleagues looked at health care from a different lens. They found that it would make a lot more sense to think about health and health care as an investment rather than a cost to be controlled and managed downward. And what makes me excited about some of the things that they found and some of the messages that come out of it, which I think a great message for most people working in the health care industry and are concerned and interested in health and well-being more broadly. First, they found that using interventions that already exist today, the global disease burden could be reduced by about 40 percent over the next two decades, 40 percent.

Saul Marquez:
Significant.

Tobias Silberzhan:
Better applying what we have already today. If one translates that in terms of life expectancy and more importantly, I feel sort of what is the amount of life you have in good health? They pretty much found that pretty much sixty-five, the age of sixty-five would be the new fifty-five if you realize the health improvement opportunity. And that of course would be a big deal because today, at least in a lot of the Western community, in some countries, life expectancy often still increases, but additional life expectancy is life being spent in poor health, whereas of course, everyone is much more excited about additional life being spent in good health.

Saul Marquez:
I heard it called health span versus lifespan.

Yeah, exactly. Exactly. I completely agree. If one then thinks about it in that respect from a sixty-five would be a 55. I think that’s an exciting and very positive message. I think the third message that that got me extremely excited about this study is that 40 percent of these health improvements could be delivered at less than one hundred dollars for each additional life year. So in that sense, there is sort of a lot of value on the table. And it’s not like crazy expensive value on the table, but it is affordable value if one looks at it from a health sort of intervention versus cost kind of curve. And I think that is another very promising thought. If one thinks about health and wellbeing from a more system level. And then finally and that’s actually what I find personally most exciting, is really thinking about health and health care from an investment perspective. If you’re a leader in the country thinking about health care as an investment. That’s right. And they are they found that pretty much every dollar invested in health care in that way would have a return of investment of two to four dollars. I think that is something that’s very exciting because in the past it has been very much that discussion of health care as that cost, but health care as an investment. And actually, how do we want to live our health and well-being and how do we want to think about health care investment in health care economics? I think it’s a hugely exciting topic.

Saul Marquez:
Yeah, think it’s a good call out, you know, and investment is a better way to look at it. It’s the health of a nation. The health of a region certainly contributes to the wealth of that area. And so I think it’s a great call-out. You know, the marginal investment I was about to call it cost. I mean, one hundred dollars per person per life-year for forty percent improvement. That’s cheap and why not? And so for those of you watching this and listening to our podcast today, it’s certainly something to think about these approaches and how we could tackle some of the largest challenges in our current health care environment Tobias is bringing up some great points for us to consider and also challenge your model, challenge your model, because there’s an opportunity to do more and to do better. So, Tobias, this is awesome. I’ve really enjoyed the discussion today and the insights you provided. And I’m sure the listeners and viewers have to before we conclude. I wish we could spend another hour together here, but obviously, maybe we’ll do a part two if you’re up for it. But really, before we conclude, give us a closing thought and the best place where the audience today can get in touch with you and the people on your team to continue the conversation if something today resonated with them.

Tobias Silberzhan:
Sure. Happy to. I guess for the closing thought, I just want to come back to what is so many people’s mind these days? How can we manage COVID-19 and how can we actually put something in place that can help the providers, the physicians, the nurses? How can we help patients and how can we save people’s lives? Coming back to what I said earlier, that is actually quite some thinking out there, how digital health solutions such as patient remote monitoring can be implemented and can be scaled. And a few thoughts for people in various regions, cities or countries listening to that. That is sort of a whole model around primary care, digital health solutions. Well, pilot studies have shown that the doctors in primary care practices like GP outpatient practices, they can be actually trained and unboarded very quickly onto something like patient remote monitoring. And this can be integrated also into websites so that patients don’t need to show up in person or patients don’t need to call in. You can actually link that to two websites, have a few triaging questions on there, which, of course, is also relevant in autumn when distinguishing a bit between cold versus influenza versus COVID-19 and then linking that To patient remote monitoring, for example, download of an app. If I just contrast that with when I just had my daughter tested for COVID-19 a few days ago, which is negative. So it’s been a phone marathon until I found the right practice who was then testing on that particular day. It was a lot of paperwork. You could actually digitize a lot of these journeys pretty quickly, where you, for example, would say the patient goes onto the website and just that postcode.

Tobias Silberzhan:
Then if you try asking questions, then the patient can download the app. This app is connected to them, a doctor in a patient remote monitoring team who then follows up, for example, on one foot. Also, imagine far more central jurisdictions for countries to put into place a patient remote monitoring team at a hospital. So there are hospitals, a few of them in Europe, that have patient remote monitoring teams who are then the standing team pretty much under the leadership of a professor, also then doing patient remote monitoring. Then you could do that as sort of the solution that you have. That scale sort of can covers different hotspots in regions. But you could also see this as sort of a second line of defense where you could say in a certain municipality there are some primary care doctors being trained on that and they sort of having the first look after patients initially. And then if numbers rise, sort of the local capacity gets overpowered and you have a few hospital patients, remote monitoring teams, that stepping in right., they’re not taking over one hundred two hundred five hundred thousand patients like that. So in that sense, there’s quite a lot of knowledge out there. I’m happy to connect people who are interested in this, given the time we are living in and the autumn-winter wave that pretty much seems to have started. Just want to put that out there and happy to share some of this thinking with people who might be interested.

Saul Marquez:
Tobias, this is great. Certainly, a lot of things for us to think about as we conclude here today. And for those that want to engage with you and further continue a conversation with you to be what’s the best way they could reach out to you or connect with your team.

Tobias Silberzhan:
I guess the most pragmatic way would be to connect with me on LinkedIn. To what people can just enter my name and company name on LinkedIn. They can also find my contact email. Also, if people prefer Twitter, they can find me at T_Siberzhan on Twitter, too.

Saul Marquez:
Outstanding Tobias. Hey, this has been truly enjoyable and insightful and folks just go to outcomes rocket that health in the search bar type in Tobias and you’re going to find all the links to get in touch with Tobias as well as links to anything that we’ve discussed. I’m not sure if that research article you mentioned is available for public sharing, is it?

Tobias Silberzhan:
Happy to put that into the link.

Saul Marquez:
Ok, great. We’ll leave the research conducted by Tobias’s colleagues in the show notes. So just check all that stuff out there. It’s where you get all the synopsis of everything we’ve discussed. Tobias, big thanks to you. Really, really grateful that you made some time to be here with us today, and definitely looking forward to staying in touch.

Tobias Silberzhan:
Thank you for having me.

Saul Marquez:
Hey, Outcomes Rocket listeners, Saul Marquez here. I get what a phenomenal asset a podcast could be for your business and also how frustrating it is to navigate editing and production, monetization, and achieving the ROI you’re looking for. Technical busywork shouldn’t stop you from getting your genius into the world, though. You should be able to build your brand easily with the professional podcast that gets attention. A patched-up podcast could ruin your business. Let us do the technical busy work behind the scenes while you share your genius on the mic and take the industry stage. Visit smoothpodcasting.com to learn more. That’s smoothpodcasting.com to learn more.

Automatically convert your audio files to text with Sonix. Sonix is the best online, automated transcription service.

Sonix uses cutting-edge artificial intelligence to convert your mp3 files to text.

Audio to text transcription just got more accurate. Automated transcription is much more accurate if you upload high quality audio. Here’s how to capture high quality audio. Transcribing by hand is no longer necessary; put away those headphones. Enterprise-grade security for all of your automated transcription and translation needs. Sonix takes transcription to a whole new level. Here are five reasons you should transcribe your podcast with Sonix.

Let powerful computers do the work for you; automated transcription in minutes. Automated transcription can quickly transcribe your skype calls. All of your remote meetings will be better indexed with a Sonix transcript. Create better transcripts with online automated transcription. Do you have a podcast? Here’s how to automatically transcribe your podcasts with Sonix.

Sonix uses cutting-edge artificial intelligence to convert your mp3 files to text.

Sonix is the best online audio transcription software in 2021—it’s fast, easy, and affordable.

If you are looking for a great way to convert your audio to text, try Sonix today.